267 related articles for article (PubMed ID: 21984480)
1. Low-dose inorganic mercury increases severity and frequency of chronic coxsackievirus-induced autoimmune myocarditis in mice.
Nyland JF; Fairweather D; Shirley DL; Davis SE; Rose NR; Silbergeld EK
Toxicol Sci; 2012 Jan; 125(1):134-43. PubMed ID: 21984480
[TBL] [Abstract][Full Text] [Related]
2. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
4. Low-dose mercury heightens early innate response to coxsackievirus infection in female mice.
Penta KL; Fairweather D; Shirley DL; Rose NR; Silbergeld EK; Nyland JF
Inflamm Res; 2015 Jan; 64(1):31-40. PubMed ID: 25376339
[TBL] [Abstract][Full Text] [Related]
5. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
[TBL] [Abstract][Full Text] [Related]
6. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus-induced chronic myocarditis in murine models.
Gauntt CJ; Tracy SM; Chapman N; Wood HJ; Kolbeck PC; Karaganis AG; Winfrey CL; Cunningham MW
Eur Heart J; 1995 Dec; 16 Suppl O():56-8. PubMed ID: 8682103
[TBL] [Abstract][Full Text] [Related]
8. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.
Hufnagel G; Chapman N; Tracy S
Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity.
Fairweather D; Rose NR
Methods; 2007 Jan; 41(1):118-22. PubMed ID: 17161308
[TBL] [Abstract][Full Text] [Related]
10. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
12. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis.
Poffenberger MC; Straka N; El Warry N; Fang D; Shanina I; Horwitz MS
PLoS One; 2009 Jul; 4(7):e6207. PubMed ID: 19587788
[TBL] [Abstract][Full Text] [Related]
13. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis.
Marsland BJ; Nembrini C; Grün K; Reissmann R; Kurrer M; Leipner C; Kopf M
J Immunol; 2007 Mar; 178(6):3466-73. PubMed ID: 17339441
[TBL] [Abstract][Full Text] [Related]
14. Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice.
Xu D; Wang P; Yang J; Qian Q; Li M; Wei L; Xu W
Front Cell Infect Microbiol; 2018; 8():157. PubMed ID: 29868513
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice.
Huber SA; Feldman AM; Sartini D
Circ Res; 2006 Nov; 99(10):1109-16. PubMed ID: 17038643
[TBL] [Abstract][Full Text] [Related]
16. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
17. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
Leipner C; Grün K; Borchers M; Stelzner A
Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
[TBL] [Abstract][Full Text] [Related]
18. Update on coxsackievirus B3 myocarditis.
Fairweather D; Stafford KA; Sung YK
Curr Opin Rheumatol; 2012 Jul; 24(4):401-7. PubMed ID: 22488075
[TBL] [Abstract][Full Text] [Related]
19. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
20. Critical cytokine pathways to cardiac inflammation.
Rose NR
J Interferon Cytokine Res; 2011 Oct; 31(10):705-10. PubMed ID: 21861699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
